@ARTICLE{
author={Bilton Diana,Fajac Isabelle,Pressler Tacjana,Clancy John Paul,Sands Dorota,Minic Predrag B,Cipolli Marco,Galeva Ivanka,Sole Amparo,Quittner Alexandra L,Jumadilova Zhanna,Ciesielska Monika,Konstan Michael W},
year={2021},
title={Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection},
journal={JOURNAL OF CYSTIC FIBROSIS},
volume={20},
number={6},
pages={1010-1017},
document_type={Article},
} 

@ARTICLE{
author={Bilton Diana,Pressler Tacjana,Fajac Isabelle,Clancy John Paul,Sands Dorota,Minic Predrag B,Cipolli Marco,Galeva Ivanka,Sole Amparo,Quittner Alexandra L,Liu Keith,McGinnis John RII,Eagle Gina,Gupta Renu,Konstan Michael W},
year={2020},
title={Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis},
journal={JOURNAL OF CYSTIC FIBROSIS},
volume={19},
number={2},
pages={284-291},
document_type={Article},
} 

@ARTICLE{
author={Konstan Michael W,Geller David E,Minic Predrag B,Brockhaus Florian,Zhang Jie,Angyalosi Gerhild},
year={2011},
title={Tobramycin Inhalation Powder for P. aeruginosa Infection in Cystic Fibrosis: The EVOLVE Trial},
journal={PEDIATRIC PULMONOLOGY},
volume={46},
number={3},
pages={230-238},
document_type={Article},
}